首页|神经内分泌癌继发的膜性肾病

神经内分泌癌继发的膜性肾病

扫码查看
老年男性患者,因"反复双下肢水肿 13 年,再发半月"入院,伴随原发灶未明的低分化神经内分泌癌病史 2 年,两次肾活检皆提示膜性肾病,13 年前肾活检组织抗磷脂酶A2 受体(PLA2R)荧光染色阳性,Ⅰ型血小板域蛋白7A(THSD7A)染色阴性,此次肾活检组织PLA2R染色阴性,THSD7A染色阳性,转移性腹股沟淋巴结活检组织THSD7A染色阳性,结合临床、实验室检查及病理最终诊断为神经内分泌癌继发膜性肾病(THSD7A相关),该疾病系国内首次报道.
Membranous nephropathy secondary to metastatic neuroendocrine carcinoma
We report a case of an elderly male for the first time in China who was admitted to hospital complaining of repeated edema of both lower limbs for 13 years and recurrence for half a month.This patient had a history of poorly differentiated neuroendocrine carcinoma with unknown primary lesion for 2 years and had undergone two renal biopsies on January 22,2009 and December 1,2022,both of which showed membranous nephropathy and no significant difference in light microscopy,immunofluorescence and electron microscopy.The first renal biopsy tissue was positive for phospholipase A2 receptor antibody(PLA2R AB)fluorescence staining and negative for thysopermatin domain containing 7A(THSD7A)staining.The latest renal biopsy tissue was negative for PLA2R staining and positive for THSD7A staining,and the metastatic inguinal lymph node biopsy tissue was positive for THSD7A staining.The final diagnosis was membranous nephropathy secondary to neuroendocrine carcinoma(THSD7A-related)based on clinical,laboratory and pathological findings.

neuroendocrine carcinomasecondary membranous nephropathythysopermatin domain containing 7A

蒋知凡、邱丹丹、梁丹丹、刘正钊、张涛

展开 >

江苏省人民医院(南京医科大学第一附属医院)老年肾科(南京,210029)

东部战区总医院 国家肾脏疾病临床医学研究中心

神经内分泌癌 继发性膜性肾病 Ⅰ型血小板域蛋白7A

国家自然科学基金面上项目伊型州临床医学研究院研究基金项目江苏省人民医院拔尖人才项目

81970638y12021ms01YNRCZN0314

2024

肾脏病与透析肾移植杂志
金陵医院肾脏病研究所

肾脏病与透析肾移植杂志

CSTPCD
影响因子:1.091
ISSN:1006-298X
年,卷(期):2024.33(4)